Ovarian tissue transplant from sister to sister for early menopause
Part of Hormones & metabolism, Women’s health & pregnancy clinical trials.
This trial transplants ovarian tissue from a healthy sister to a woman with early menopause, so she might be able to get pregnant. The study will see if this approach is safe and effective in restoring fertility.
Summary written for real people, not researchers, by Clin2.
Who can take part
- The donor must be a genetic sister of the recipient, aged 21 to 35.
- The donor must have had at least one healthy baby and must have both ovaries.
- The recipient must be aged 21 to 40 and in a committed relationship with a male partner.
- The recipient must have been offered donor egg IVF and declined it.
- Both donor and recipient must be willing to have surgery and take strong medicines to prevent rejection.
- The recipient must be willing to try to get pregnant naturally within 4 months after the transplant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether a “mechanical stimulation” procedure can help small egg-making structures in the ovary start to work again in people with primary ovarian insufficiency. If the procedure shows signs of response, you may then move on to further fertility treatment, including IVF.
This study tests whether using a special mix made from your own blood (called platelet-rich plasma) can improve the success of putting frozen ovarian tissue back into your body. This might help restore your fertility and hormone function after cancer treatment or other conditions.
This trial studies whether an injection of your own PRP (platelet-rich plasma) can improve how your ovaries work in people with early ovarian failure. If it helps, it may lead to better hormone balance and return of more regular ovulation and periods.
This study helps people who are about to start cancer treatment (or have certain health conditions) preserve their ability to have children later. It removes and freezes a small piece of ovarian tissue before treatments that could damage the ovaries.
This trial tests whether injecting your own PRP (platelet-rich plasma) into the ovaries can improve ovarian function in some menopausal women. It may help those whose menopause seems less advanced, but not everyone will be eligible based on health and test results.
This trial tests whether receiving a uterus transplant can allow someone with uterine absence to carry a pregnancy. It also looks at whether the procedure is safe for the patient and supports a future baby using frozen embryos.
Hear when a new Ovarian Insufficiency trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.